FDA letter monthly archive

FDA Letters Issued in September 2019

Name: FDA Letters Issued in September 2019
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in September 2019. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter AstraZeneca AB (Sep 30, 2019)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Clinical efficacy and substantial evidence, Device constituent and human factors, Safety and adverse events. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedSep 30, 2019
US FDA• BREZTRI AEROSPHERE

Complete Response Letter AstraZeneca AB (Sep 30, 2019)